Final Glance: Biotechnology companies
AP - Thu Aug 07, 5:13PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
Midday Glance: Biotechnology companies
AP - Thu Aug 07, 12:31PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Early Glance: Biotechnology companies
AP - Thu Aug 07, 9:58AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Zacks Earnings Trends Highlights: Intel, Micron Technology, Apple, Gilead Sciences and Verizon
PR Newswire - Thu Aug 07, 8:30AM CDT
Zacks Director of Research Sheraz Mian says, "The reduced negative revisions rate at this stage in the reporting cycle is the most notable positive element of this earnings season."
Q3 Earnings Estimates Not Falling As Much - Earnings Trends
Sheraz Mian - Zacks Investment Research - Wed Aug 06, 4:01AM CDT
Q3 Earnings Estimates Not Falling As Much - Earnings Trends
Q3 Earnings Estimates Not Falling As Much - Earnings Outlook
Sheraz Mian - Zacks Investment Research - Wed Aug 06, 4:01AM CDT
Q3 Earnings Estimates Not Falling As Much - Earnings Outlook
'Fast Money' Recap: Is Michael Kors Still in Fashion?
at The Street - Tue Aug 05, 4:00AM CDT
The trading panel looked at Michael Kors' earnings, Microsoft, steel stocks and biotechs.
Gilead Sciences (GILD) Approaches New Upside Target of $93.51
Comtex SmarTrend(R) - Mon Aug 04, 9:02AM CDT
Gilead Sciences (NASDAQ:GILD) has opened bullishly above the pivot of $91.60 today and has reached the first level of resistance at $92.50. Investors may be interested in a cross of the next upside pivot targets of $93.51 and $95.42.
Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver
PR Newswire - Mon Aug 04, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GRPN, GILD, BLDP, GSK, and LLY.
Doctor Evidence Partnering with Healthcare Decision-Makers on Hepatitis C Evidence
PRWeb - Sun Aug 03, 5:30AM CDT
Doctor Evidence ("DRE"
TAL Education, Team Health Join The IBD 50 Resistance
at Investor's Business Daily - Fri Aug 01, 6:08PM CDT
Leading stocks took their licks in the past week, with only a small clique of IBD 50 stocks posting weekly gains. Among those, China-based TAL Education (XRS) hauled in an 11% gain to end the week at a new high. That left the chain of tutoring...
Pharmacyclics Q2 Earnings Get Mixed Reception
at Investor's Business Daily - Fri Aug 01, 11:35AM CDT
Biotech Pharmacyclics (PCYC) was seesawing on the stock market today after its Q2 sales beat consensus late Thursday, but the company declined to update its guidance. Pharmacyclics' sales more than doubled over the year-earlier quarter to $113...